Genotype–phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin

Molecular Genetics and Metabolism - Tập 88 Số 1 - Trang 78-85 - 2006
J. Martijn Bos1, Rainer N. Poley2, Melissa Ny3, David J. Tester3, Xiaolei Xu4, Matteo Vatta5,6,7, Jeffrey A. Towbin5,6, Bernard J. Gersh1, Steve R. Ommen1, Michael J. Ackerman1,3,8
1Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
2Mayo Medical School, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
3Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
4Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA;
6Department of Pediatrics (Cardiology), Baylor College of Medicine, Houston, TX, USA
7Department of Reproductive and Developmental Sciences, University of Trieste, Trieste, Italy
8Department of Pediatrics, Division of Pediatric Cardiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Maron, 2002, Hypertrophic cardiomyopathy: a systematic review, JAMA, 287, 1308, 10.1001/jama.287.10.1308

Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults, Circulation, 92, 785, 10.1161/01.CIR.92.4.785

Geisterfer-Lowrance, 1990, A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation, Cell, 62, 999, 10.1016/0092-8674(90)90274-I

Poetter, 1996, Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle, Nat. Genet., 13, 63, 10.1038/ng0596-63

Watkins, 1995, Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy, Nat. Genet., 11, 434, 10.1038/ng1295-434

Thierfelder, 1994, Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere, Cell, 77, 701, 10.1016/0092-8674(94)90054-X

Kimura, 1997, Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy, Nat. Genet., 16, 379, 10.1038/ng0897-379

Olson, 2000, Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy, J. Mol. Cell. Cardiol., 32, 1687, 10.1006/jmcc.2000.1204

Mogensen, 1999, Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy, J. Clin. Invest., 103, R39, 10.1172/JCI6460

Van Driest, 2005, Sarcomeric genotyping in hypertrophic cardiomyopathy, Mayo Clin. Proc., 80, 463, 10.4065/80.4.463

Van Driest, 2005, Yield of genetic testing in hypertrophic cardiomyopathy, Mayo Clin. Proc., 80, 739, 10.4065/80.6.739

Genomics of Cardiovascular Development, Adaptation, and Remodelling. NHLBI Program of Genomic Applications, Harvard Medical School, <http://www.cardiogenomics.org> (accessed 09/30/05).

Richard, 2003, Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy, Circulation, 107, 2227, 10.1161/01.CIR.0000066323.15244.54

Van Driest, 2004, Myosin binding protein C mutations and compound herterozygosity in hypertrophic cardiomyopathy, J. Am. Coll. Cardiol., 44, 1903, 10.1016/j.jacc.2004.07.045

Van Driest, 2004, Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy, J. Am. Coll. Cardiol., 44, 602, 10.1016/j.jacc.2004.04.039

Erdmann, 2001, Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy, J. Am. Coll. Cardiol., 38, 322, 10.1016/S0735-1097(01)01387-0

Morner, 2003, Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden, J. Mol. Cell. Cardiol., 35, 841, 10.1016/S0022-2828(03)00146-9

Garcia-Castro, 2003, Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients, Clin. Chem., 49, 1279, 10.1373/49.8.1279

Jaaskelainen, 1998, The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population, J. Am. Coll. Cardiol., 32, 1709, 10.1016/S0735-1097(98)00448-3

Jaaskelainen, 2002, Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland, J. Mol. Med., 80, 412, 10.1007/s00109-002-0323-9

Hayashi, 2004, Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy, J. Am. Coll. Cardiol., 44, 2192, 10.1016/j.jacc.2004.08.058

Geier, 2003, Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy, Circulation, 107, 1390, 10.1161/01.CIR.0000056522.82563.5F

Gerull, 2002, Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy, Nat. Genet., 30, 201, 10.1038/ng815

Itoh-Satoh, 2002, Titin mutations as the molecular basis for dilated cardiomyopathy, Biochem. Biophys. Res. Commun., 291, 385, 10.1006/bbrc.2002.6448

Labeit, 1995, Titins: giant proteins in charge of muscle ultrastructure and elasticity, Science, 270, 293, 10.1126/science.270.5234.293

Valle, 1997, Telethonin, a novel sarcomeric protein of heart and skeletal muscle, FEBS Lett., 415, 163, 10.1016/S0014-5793(97)01108-3

Fung, 1995, Mapping of a human LIM protein (CLP) to human chromosome 11p15.1 by fluorescence in situ hybridization, Genomics, 28, 602, 10.1006/geno.1995.1200

Satoh, 1999, Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene, Biochem. Biophys. Res. Commun., 262, 411, 10.1006/bbrc.1999.1221

Ackerman, 2002, Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T gene in hypertrophic cardiomyopathy: a comprehensive outpatient perspective, J. Am. Coll. Cardiol., 39, 2042, 10.1016/S0735-1097(02)01900-9

Van Driest, 2003, Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy, Circulation, 108, 445, 10.1161/01.CIR.0000080896.52003.DF

Newman, 2005, W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy, Mol. Genet. Metab., 84, 374, 10.1016/j.ymgme.2004.11.013

Hayashi, 2004, Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun., 313, 178, 10.1016/j.bbrc.2003.11.101

Mohapatra, 2003, Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis, Mol. Genet. Metab., 80, 207, 10.1016/S1096-7192(03)00142-2

Knoll, 2002, The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy, Cell, 111, 943, 10.1016/S0092-8674(02)01226-6

Van Driest, 2005, Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy, Mol. Genet. Metab., 1096

Arber, 1997, MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure, Cell, 88, 393, 10.1016/S0092-8674(00)81878-4